Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–2917.

Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020–1022.

Llovet JM, Bruix J . Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48: 1312–1327.

Razzaque MA, Masuda N, Maeda Y, Endo Y, Tsukamoto T, Osumi T . Estrogen receptor-related receptor gamma has an exceptionally broad specificity of DNA sequence recognition. Gene 2004; 340: 275–282.

Giguere V . To ERR in the estrogen pathway. Trends Endocrinol Metab 2002; 13: 220–225.

Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ . Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006; 126: 789–799.

Giguere V . Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008; 29: 677–696.

Riggins RB, Lan JP, Zhu Y, Klimach U, Zwart A, Cavalli LR et al. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 2008; 68: 8908–8917.

Heckler MM, Thakor H, Schafer CC, Riggins RB . ERK/MAPK regulates ERRgamma expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer. FEBS J 2014; 281: 2431–2442.

Ren Z, Yang H, Wang C, Ma X . The effects of PGC-1alpha on the proliferation and energy metabolism of malignant endometrial cancer cells. Onco Targets Ther 2015; 8: 769–774.

Sun Y, Wang C, Yang H, Ma X . The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRgamma through AKT and ERK1/2. Eur J Cancer Prev 2014; 23: 418–424.

Lapenna S, Giordano A . Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 2009; 8: 547–566.

Waldman T, Kinzler KW, Vogelstein B . p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55: 5187–5190.

Gartel AL, Tyner AL . The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639–649.

Senderowicz AM . Small-molecule cyclin-dependent kinase modulators. Oncogene 2003; 22: 6609–6620.

Bianco S, Sailland J, Vanacker JM . ERRs and cancers: effects on metabolism and on proliferation and migration capacities. J Steroid Biochem Mol Biol 2012; 130: 180–185.

Deblois G, Hall JA, Perry MC, Laganiere J, Ghahremani M, Park M et al. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res 2009; 69: 6149–6157.

Bernatchez G, Giroux V, Lassalle T, Carpentier AC, Rivard N, Carrier JC . ERRalpha metabolic nuclear receptor controls growth of colon cancer cells. Carcinogenesis 2013; 34: 2253–2261.

Cheung CP, Yu S, Wong KB, Chan LW, Lai FM, Wang X et al. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J Clin Endocrinol Metab 2005; 90: 1830–1844.

Yu S, Wong YC, Wang XH, Ling MT, Ng CF, Chen S et al. Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer. Oncogene 2008; 27: 3313–3328.

Bianco S, Lanvin O, Tribollet V, Macari C, North S, Vanacker JM . Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem 2009; 284: 23286–23292.

Edge SB, Compton CC . The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471–1474.

Llovet JM, Bru C, Bruix J . Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329–338.

Lee YJ, Hah YJ, Kang YN, Kang KJ, Hwang JS, Chung WJ et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PLoS ONE 2013; 8: e81540.

Sanyal S, Kim JY, Kim HJ, Takeda J, Lee YK, Moore DD et al. Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. J Biol Chem 2002; 277: 1739–1748.

Chao EY, Collins JL, Gaillard S, Miller AB, Wang L, Orband-Miller LA et al. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. Bioorg Med Chem Lett 2006; 16: 821–824.

Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut 2012; 61: 1481–1487.

Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007; 45: 725–734.

International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009; 49: 658–664.

Kim DK, Ryu D, Koh M, Lee MW, Lim D, Kim MJ et al. Orphan nuclear receptor estrogen-related receptor gamma (ERRgamma) is key regulator of hepatic gluconeogenesis. J Biol Chem 2012; 287: 21628–21639.

Park YY, Kim SH, Kim YJ, Kim SY, Lee TH, Lee IK et al. Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRgamma). Biochem Biophys Res Commun 2007; 362: 107–113.